cp wire

CP Wire Articles

ContraFect Corporation Prices $10 Million Public Offering of Common Stock to Develop Novel Infectious Disease Treatments


ContraFect Corporation (Nasdaq:CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-... read more

Mon, 07/30/18 - 09:45 am
HitGen and Merck Expand Collaboration to Build Novel DNA-Ecoded Libraries for Drug Discovery
  • HitGen also recently announced collaboration with Sanofi
  • The company's DNA Encoded Libraries contain more than 200 billion drug like compounds


HitGen Ltd. Announced... read more

Mon, 07/30/18 - 09:28 am
BeiGene Proposes $800+ Million Offering


 BeiGene, Ltd. (NASDAQ:BGNE) announced on 7/27/18 a Hong Kong initial public offering and a global offering (the “Offering”) of 65,600,000 of its ordinary shares and the proposed listing of... read more

Fri, 07/27/18 - 10:37 am
Alnylam Receives Positive CHMP Opinion for Hereditary Amyloidosis Treatment
  • European Medicines Agency reviewed patisiran under the accelerated assessment procedure
  • Patisiran is currently under priority review as a Breakthrough Therapy with the US FDA
    • ... read more
Fri, 07/27/18 - 10:01 am
Keytruda Becomes the First Anti-PD-1 Therapy Approved in China for Advanced Melanoma



Merck (NYSE:MRK) announced on 7/26/18 that Keytruda, Merck’s anti-PD-1 therapy, has been approved by the China National Drug Administration (CNDA) for the treatment of adult patients with... read more

Thu, 07/26/18 - 09:47 am

Pages